NL7201429A - Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii - Google Patents

Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii

Info

Publication number
NL7201429A
NL7201429A NL7201429A NL7201429A NL7201429A NL 7201429 A NL7201429 A NL 7201429A NL 7201429 A NL7201429 A NL 7201429A NL 7201429 A NL7201429 A NL 7201429A NL 7201429 A NL7201429 A NL 7201429A
Authority
NL
Netherlands
Prior art keywords
factor
factor viii
antiserum
antihaemophilia
determination
Prior art date
Application number
NL7201429A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL7201429A priority Critical patent/NL7201429A/en
Publication of NL7201429A publication Critical patent/NL7201429A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The antiserum (I) is obtained by minimising animals with a human plasma cryopreciptate fraction rich in Factor VIII, prepd. as in Biochem.Biophys.Acta 1970,221, 677-9, isolating the serum, and adsorbing with normal human plasma or plasma from patients with Willebrands disease or haemophilia A to eliminate non-specific antibodies. I can be used in the diagnosis and differentiation of haemophilia and Willebrand's disease.
NL7201429A 1972-02-03 1972-02-03 Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii NL7201429A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7201429A NL7201429A (en) 1972-02-03 1972-02-03 Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7201429A NL7201429A (en) 1972-02-03 1972-02-03 Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii

Publications (1)

Publication Number Publication Date
NL7201429A true NL7201429A (en) 1973-08-07

Family

ID=19815284

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7201429A NL7201429A (en) 1972-02-03 1972-02-03 Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii

Country Status (1)

Country Link
NL (1) NL7201429A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357899A1 (en) * 1976-03-08 1978-02-03 Leuven Res & Dev Vzw PROCESS FOR PURIFICATION OF AN ANTISERUM GENERATED AGAINST AN ENZYME-INHIBITOR COMPLEX FORMING PART OF THE BLOOD COAGULATION SYSTEM OR OF THE FIBRINOLYTIC SYSTEM ACTIVE IN BLOOD PLASMA

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357899A1 (en) * 1976-03-08 1978-02-03 Leuven Res & Dev Vzw PROCESS FOR PURIFICATION OF AN ANTISERUM GENERATED AGAINST AN ENZYME-INHIBITOR COMPLEX FORMING PART OF THE BLOOD COAGULATION SYSTEM OR OF THE FIBRINOLYTIC SYSTEM ACTIVE IN BLOOD PLASMA

Similar Documents

Publication Publication Date Title
NO892985D0 (en) NEW, FIXED AND POROEST UNIT ELEMENT INCLUDING MICROPARTICLES AND / OR NANOPARTICLES AND PROCEDURES FOR PRODUCING THEREOF.
DE3682457D1 (en) DEVICE FOR THE ADMINISTRATION OF MEDICINES TO PATIENTS.
SU698518A3 (en) Device for saturation of blood with oxygen
YU48299B (en) PROCEDURE FOR THE PRODUCTION OF A RANSDERMAL THERAPEUTIC SYSTEM FOR Bringing ACTIVE MATERIAL TO THE SKIN
DE68910159D1 (en) Dosage form for administration in human medicine.
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
DE3769707D1 (en) THERAPEUTIC SYSTEM WITH REGULATED DELIVERY OF ACTIVE SUBSTANCES.
ATE74001T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM.
SE8505047D0 (en) fat emulsion
FI883688A (en) MOLEKYLAER KLONING OCH EXPRESSION AV HUMANT INTERLEUKIN-3.
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
ATE220912T1 (en) PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING ST1435 FOR TOPICAL USE
SE400703B (en) MEDICAL DEVICE FOR SATURATION OF THE BLOOD VALVE
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
NL7201429A (en) Factor viii (antihaemophilia factor a) antiserum - -determination of factor viii
SE7707889L (en) HAPTOGLOBIN PREPARATION
JPS51128414A (en) Medicine consisting of biological active polypeptide
JPS5283911A (en) Fat emulsion for intravenous injection
DE68928061D1 (en) EXPRESSION OF PROTEIN SWEETENERS IN YEAST
FR2382237A1 (en) NEW MERCAPTAN-BASED BLOOD SERUM PREPARATIONS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
SU605608A1 (en) Method of studying branches of main blood vessels
GB1142571A (en) A new polypeptide, and a method of preparing it
GB1339737A (en) Diagnostic agents for primary hepatoma
FR1516352A (en) Method for determining the bilirubin content of fluids in the human body, in particular serum and urine
IT8967049A0 (en) MONOCLONAL HUMAN ANTIBODY THERAPEUTIC COMPOSITION THAT CONTAINS IT CELL LINE CAPABLE OF PRODUCING THE ANTIBODY PROCEDURE FOR ITS PRODUCTION